Test whole-blood transfusion plan for severe malaria in young children
Part of Blood & lymphatic, Infections clinical trials.
This trial studies a platelet-focused strategy for giving whole blood to children under 5 with severe malaria. It aims to see whether this approach can improve care while keeping children safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be younger than 5 years old
- Have a platelet count of 75,000 or less (a blood cell that helps clot)
- Have hemoglobin higher than 5 and up to 9 (a blood measure of oxygen-carrying capacity)
- Have malaria caused by Plasmodium falciparum with enough parasites in the blood
- Be diagnosed with severe malaria based on WHO criteria
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving malaria prevention medicine after hospital discharge helps prevent another serious malaria episode in young children. If your child was hospitalized for severe anemia or severe malaria, this study may offer additional protection.
This study tests a malaria treatment called PDMC in children under 10 who are in the hospital with severe anemia or severe malaria. It aims to see if this treatment can help prevent further health problems.
This study looks at severe malaria in children from remote areas. It compares children with malaria, children with other severe fevers, and those with uncomplicated malaria to improve treatment in hard-to-reach villages.
This study is testing whether giving smaller volumes of platelet transfusions to premature babies with very low platelet counts is as effective as the standard larger volume. It aims to find a safer way to prevent bleeding while reducing risks like fluid overload.
This study looks at the best way to decide when to give platelet transfusions to very premature babies. It aims to help prevent bleeding while avoiding unnecessary transfusions.
This early-stage study tests how a medicine (involving ondansetron and ceftriaxone) works in people with malaria. It especially focuses on children with cerebral malaria to see if it can improve safety and early effectiveness.
Hear when a new Severe Malaria trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.